Drug Shortage Report for DANTROLENE SODIUM FOR INJECTION, USP
Report ID | 231326 |
Drug Identification Number | 02529998 |
Brand name | DANTROLENE SODIUM FOR INJECTION, USP |
Common or Proper name | DANTROLENE SODIUM FOR INJECTION, USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DANTROLENE SODIUM |
Strength(s) | 20MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 20mg |
ATC code | M03CA |
ATC description | MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-07-12 |
Actual start date | |
Estimated end date | 2024-07-31 |
Actual end date | 2024-08-29 |
Shortage status | Resolved |
Updated date | 2024-09-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-09-03 | French | Compare |
v4 | 2024-09-03 | English | Compare |
v3 | 2024-07-13 | English | Compare |
v2 | 2024-06-26 | French | Compare |
v1 | 2024-06-26 | English | Compare |
Showing 1 to 5 of 5